Investing.com - AbbVie (NYSE:ABBV) reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AbbVie announced earnings per share of $3.11 on revenue of $13.96B. Analysts polled by Investing.com anticipated EPS of $3.08 on revenue of $13.63B.
AbbVie shares are up 10% from the beginning of the year and are trading at $117.40 , down-from-52-week-high.They are under-performing the S&P 500 which is up 17.65% from the start of the year.
AbbVie shares lost 1.24% in pre-market trade after the report.
AbbVie follows other major Healthcare sector earnings this month
AbbVie's report follows an earnings beat by HCA on Tuesday, July 20, 2021, who reported EPS of $4.37 on revenue of $14.44B, compared to forecasts EPS of $3.16 on revenue of $13.61B.
Centene had beat expectations on Tuesday with second quarter EPS of $1.25 on revenue of $31.03B, compared to forecast for EPS of $1.22 on revenue of $30.19B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar